Immatics N V stock is traded at $6.91, with a volume of 678,887. It is down -2.33% in the last 24 hours and down -8.96% over the past month. Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Previous Close:
$7.08
Open:
$7.25
24h Volume:
678,887
Relative Volume:
0.62
Market Cap:
$1.05B
Revenue:
$43.34M
Net Income/Loss:
-$247.99M
P/E Ratio:
-
EPS:
-$1.97
Net Cash Flow:
-$224.28M
1W Performance:
-5.99%
1M Performance:
-8.96%
6M Performance:
-37.97%
1Y Performance:
-25.30%
1-Day Range:
$6.89$7.52
1-Week Range:
$6.81$7.52
52-Week Range:
$6.65$12.41
Immatics N V Stock (IMTX) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS